AzTrials
AzTrials

HypertensionDIADSNCT01892592

Discovering Healthcare Innovations to Address Disparities in Stroke (DIADS)

A study testing Diet and Lifestyle in people with Hypertension, run by Kaiser Permanente at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The goal of this pragmatic study is to improve hypertension (HTN) control rate in blacks and to reduce racial disparity in HTN control. To accomplish this, the investigators propose to perform a cluster randomized controlled trial at the primary care provider (PCP) level and including 191 PCPs within KPNC East Bay… Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
Conditions the study is for
Hypertension
What is being tested?
Diet and Lifestyle
Could I receive a placebo?
No, everyone receives an active treatment
How many people
1,761 participants
Where
1 siteUnited States
Study dates
Jun 2013to Jun 2018
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • African American
  • > age 18
  • Blood Pressure >140/90

Who cannot join

  • -

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Kaiser Permanene Oakland Medical Center

    Oakland, California, 94611

Other trials in United States

About this study

Official title: Discovering Healthcare Innovations to Address Disparities in Stroke

The goal of this pragmatic study is to improve hypertension (HTN) control rate in blacks and to reduce racial disparity in HTN control. To accomplish this, the investigators propose to perform a cluster randomized controlled trial at the primary care provider (PCP) level and including 191 PCPs within KPNC East Bay Service Area with more than 45,000 patients in the HTN registry of which approximately 15,000 are black. The investigators will randomize all PCP patient panels to a three-arm trial to receiving either 1) usual care; or 2) culturally tailored diet and lifestyle coaching; or 3) an intensified BP management protocol with pharmacotherapy. The "Shake, Rattle and Roll" trial is named for: 1) "shake" the salt habit; 2) "rattle" the intensity of current BP management; and 3) design the interventions with the goal of being able to adapt and "roll" them out to community clinics outside of a managed care system. Primary research question: whether a primary prevention intervention of either diet and lifestyle coaching or an intensive pharmacotherapy protocol is more effective than usual care in improving rates of HTN control in blacks and thereby reducing disparities between black and white. Primary aim: By implementing either intervention, the investigators will reduce the disparity in hypertension control rates between blacks and whites by 4% at 1 year post-study enrollment. Hypothesis: Among blacks with HTN, a diet/lifestyle coaching intervention or an intensified BP management protocol will result in an increase in HTN control rate compared to usual care. Primary outcome: the proportion of patients with sustained BP control at 1 year post-study enrollment.

Read the detailed description

Kaiser Permanente Northern California (KPNC) serves a population of over 3 million enrollees, representative of the socio-demographic characteristics of the San Francisco Bay Area, Santa Rosa, and Sacramento except for under-representation of the very rich and very poor.78 KPNC is the largest nonprofit integrated health care organization in the country, with 22 hospitals and 44 outpatient facilities, and cares for 30% of the population in the region. The majority of Californians are managed in four large hospital networks, so the KPNC system is a model for the 167 Program Director/Principal Investigator (Last, First, Middle): Sidney, Stephen, MD, MPH PHS 398/2590 (Rev. 06/09) Page Continuation Format Page prevalent system of care in the state. An effective system-wide intervention in KPNC would likely be generalizable and feasible in the other healthcare networks in the State and, thus, could benefit the population more broadly. The project focuses on the East Bay Service Area (EBSA) because approximately one-third of African American KPNC members with HTN receive care within this geographical area. The East Bay area, home of the flagship Oakland Medical Center and Richmond Medical Center, comprises 12 cities and municipalities within the Alameda County and the western section of Contra Costa County. From Kaiser Permanente's inception in 1945, the nonprofit organization has led with innovation, beginning with its prepaid health care services offered to Richmond shipyard workers during World War II. Today, the Richmond and Oakland Medical Centers are home to about 700 physicians and 5,600 employees who serve over a quarter of a million members yearly.

Kaiser Permanente East Bay has expanded its services for West Contra Costa members. The brand new Pinole Medical Office Building, just eight miles from the Richmond Medical Center offers convenient access to members in the East Bay Area, which includes Pinole, El Sobrante, Hercules, Rodeo and Crockett.

The Pinole center provides adult medicine, family practice, pediatrics, obstetrics/gynecology, radiology, a lab, a pharmacy, and health education. For emergency services, members go to the Richmond Medical Center, and for labor and delivery services, the Oakland Medical Center. The fourth member of the EBSA is the Alameda Medical Center which offers services for internal medicine, gynecology, pediatrics, pharmacy, and members outreach. Using KPNC as a model offers several major advantages. Members generally remain in the plan for many years, with 94% retention at 1 year and 84% retention at 5 years among enrollees 65-74 years old.

Sources of electronic medical data are extensive and easy to manipulate. They will be combined to produce an electronic registry of patients with uncontrolled HTN (Figure - Electronic Registry; source of data provided in brackets). The following information is available from electronic medical record (EMR) system:

  • Inpatient discharge abstracts with primary and secondary diagnoses and procedures coded by a trained medical records analyst.
  • Inpatient discharge abstracts for all out-of-plan hospital admissions.
  • Emergency-department and outpatient diagnoses coded by the treating physician.
  • All outpatient records including BP measurements.
  • All radiology reports generated by reviewing radiologists.
  • Listing of all major health problems generated and frequently updated by all treating physicians.
  • Cardiologist interpretations of all ECGs.
  • Reports from all clinical laboratory studies.
  • Listing of all outpatient filled prescriptions and completed inpatient medication orders.

The EMR databases have been validated extensively and, in combination, have been shown to accurately reflect a number of disease diagnosis, comorbidities, and outcomes.79-81 The KPNC Division of Research maintains a mortality database for all KPNC members dating back to 1971. The primary sources of mortality data are the California Department of Health Services, which maintains a registry of deaths and their causes, and Social Security mortality files for more recent deaths. With the recent loss of the utility of the Social Security mortality files, we have made arrangements to have more frequent updates (quarterly or semi-annually) from the California Department of Health Services so that our mortality file will be current until the approximately past 6 months. Mortality will also be assessed from the KPNC EMR if they occur during a hospitalization. The "Shake, Rattle and Roll" trial is named for: 1) "shake" the salt habit; 2) "rattle" the intensity of the current clinical BP protocol; and 3) design the interventions with the ultimate goal of being able to adapt and "roll" out the interventions to community clinics outside of the managed care system.

Randomization There are 194 PCPs in the EBSA with 191 providers having African Americans in their patient panels.

The unit of randomization will be the primary care providers in the EBSA (N=191) who have black patients in their panels. The other 3 PCPs can be randomized into the study at a later date if and when they add African American patients to their panels. All PCPs will be randomized to one of the 3 arms. To the extent possible, we will strive to have an approximately equal number of African Americans with HTN in each arm of the trial (approximately 1896 with uncontrolled HTN expected per group). This will be accomplished by using stratified black patients with hypertension in each clinician's panel.

With the intensified BP protocol intervention, because it is a quality improvement effort, randomizing at the provider level will allow all African American patients with HTN to be targeted for the intervention should their BP ever become uncontrolled. We will not need to ask patients if they are willing to participate given the intervention is an extension of the usual care model with more intensive focus on aggressive HTN management for African Americans. We will seek a waiver of informed consent for the intervention from our local Institutional Review Board (IRB) and have been advised by the IRB administrator that the waiver will likely be approved by the IRB.

Being able to include all African Americans in this intervention will increase the generalizability of the study findings. With the diet and lifestyle coaching intervention, randomizing at the provider level will also allow us to invite all African American patients with uncontrolled HTN to participate in this intervention. Even though the materials used in developing this intervention are available within KPNC, a formal coaching program for diet and lifestyle effects on HTN is currently non-existent. We will send out letters to inform eligible patients of this on-going improvement project. The patients will have the option of opting out of the study by returning a stamped envelope to us. If the patients choose not to opt out, then a research staff will contact them to discuss enrollment as scheduled (Figure - study diagram, above). As detailed in the Statistical Analysis Section we anticipate enrollment of approximately 1896 blacks with uncontrolled HTN to each arm of the study spread out over a 2-year period. The randomization process of all PCPs will be carried out by a programmer at the KPNC DOR offices (Oakland, CA).

Conditions
Hypertension
Being tested
Diet and Lifestyle
Keywords
Hypertension, African American, Health Disparities, Stroke, Cardiovascular Disease
Medical subject headings
Hypertension, Stroke, Cardiovascular Diseases

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Diet and LifestyleBehavioural

    Also called Behavioral Interventions, Wellenss Coaching

    Patients will receive up to 16 phone based coaching sessions

Study groups in NCT01892592
Study groupRoleWhat they receive
Usual CareNo interventionNo Interventions
Medication enhancementNo interventionPharmacist will optimize current Kaiser medication protocol for treatment of hypertension.
Diet and Lifestyle ArmExperimentalPatients will receive up to 16 wellness coaching sessions focusing on DASH doest and lifestyle changes - Behavioral Intervention
Receives: Behavioral: Diet and Lifestyle

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Percentage of Blacks / African Americans with HTY with controlled blood pressure (BP) after 1 year.

    Percentage of Blacks / African Americans with HTY with controlled blood pressure (BP) after 1 year.

    Measured: 1 year

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted4 Jul 2013 (estimated)
  2. Study startJun 2013
  3. Primary completionJun 2015
  4. Study completionJun 2018

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Single group
Masking
None (open label)
Enrolment
1,761 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01892592
Sponsor's protocol ID
CN-12SSidn-06-H
Acronym
DIADS
Status last verified
May 2022
First submitted
21 Mar 2013
Last updated
20 May 2022
Results posted
No
Data monitoring committee
No

Publications

  • Nguyen-Huynh MN, Young JD, Ovbiagele B, Alexander JG, Alexeeff S, Lee C, Blick N, Caan BJ, Go AS, Sidney S. Effect of Lifestyle Coaching or Enhanced Pharmacotherapy on Blood Pressure Control Among Black Adults With Persistent Uncontrolled Hypertension: A Cluster Randomized Clinical Trial. JAMA Netw Open. 2022 May 2;5(5):e2212397. doi: 10.1001/jamanetworkopen.2022.12397.

    PubMed 35583869
  • Nguyen-Huynh MN, Young JD, Alexeeff S, Hatfield MK, Sidney S. Shake Rattle & Roll - Design and rationale for a pragmatic trial to improve blood pressure control among blacks with persistent hypertension. Contemp Clin Trials. 2019 Jan;76:85-92. doi: 10.1016/j.cct.2018.11.012. Epub 2018 Nov 28.

    PubMed 30500558

Questions about this trial

What is this clinical trial studying?

A study testing Diet and Lifestyle in people with Hypertension, run by Kaiser Permanente at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 20 May 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Percentage of Blacks / African Americans with HTY with controlled blood pressure (BP) after 1 year. (time frame: 1 year). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT01892592, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 20 May 2022.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in